PT74246B - Process for preparing hbsag - Google Patents

Process for preparing hbsag

Info

Publication number
PT74246B
PT74246B PT74246A PT7424682A PT74246B PT 74246 B PT74246 B PT 74246B PT 74246 A PT74246 A PT 74246A PT 7424682 A PT7424682 A PT 7424682A PT 74246 B PT74246 B PT 74246B
Authority
PT
Portugal
Prior art keywords
hbsag
cells
preparing
preparing hbsag
shed
Prior art date
Application number
PT74246A
Other languages
English (en)
Other versions
PT74246A (en
Inventor
Henry Z Markus
William J Mcaleer
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT74246A publication Critical patent/PT74246A/pt
Publication of PT74246B publication Critical patent/PT74246B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT74246A 1981-01-16 1982-01-06 Process for preparing hbsag PT74246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/225,555 US4416986A (en) 1981-01-16 1981-01-16 Methods of producing HBsAg

Publications (2)

Publication Number Publication Date
PT74246A PT74246A (en) 1982-02-01
PT74246B true PT74246B (en) 1984-05-29

Family

ID=22845332

Family Applications (1)

Application Number Title Priority Date Filing Date
PT74246A PT74246B (en) 1981-01-16 1982-01-06 Process for preparing hbsag

Country Status (10)

Country Link
US (1) US4416986A (pt)
EP (1) EP0056761B1 (pt)
JP (1) JPS57141294A (pt)
AT (1) ATE6402T1 (pt)
CA (1) CA1175745A (pt)
DE (1) DE3260046D1 (pt)
DK (1) DK15382A (pt)
ES (1) ES508742A0 (pt)
GR (1) GR74755B (pt)
PT (1) PT74246B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5223428A (en) * 1982-12-14 1993-06-29 Baxter International Inc. Method for in vitro culture of mammalian cells
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
US6309635B1 (en) 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US6022742A (en) * 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
JP3117994B2 (ja) * 1990-05-16 2000-12-18 ベイラー・カレツジ・オブ・メデイシン 永久的ヒト肝細胞の細胞系および肝臓補助装置（ｌａｄ）におけるその使用
WO1993007913A1 (en) * 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US6123727A (en) 1995-05-01 2000-09-26 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5741685A (en) * 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
PL376821A1 (pl) * 2002-03-27 2006-01-09 Immunex Corporation Sposoby zwiększania produkcji polipeptydów
WO2008038641A1 (en) * 2006-09-26 2008-04-03 Kyoto University Method of proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells and utilization of the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US4220725A (en) * 1978-04-03 1980-09-02 United States Of America Capillary cell culture device
PT71739B (en) * 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
IE51173B1 (en) * 1980-03-27 1986-10-29 Merck & Co Inc Method of growing hepatitis b surface antigen

Also Published As

Publication number Publication date
ES8300473A1 (es) 1982-11-16
CA1175745A (en) 1984-10-09
ES508742A0 (es) 1982-11-16
PT74246A (en) 1982-02-01
GR74755B (pt) 1984-07-11
DK15382A (da) 1982-07-17
ATE6402T1 (de) 1984-03-15
EP0056761A1 (en) 1982-07-28
DE3260046D1 (en) 1984-04-05
EP0056761B1 (en) 1984-02-29
US4416986A (en) 1983-11-22
JPS57141294A (en) 1982-09-01

Similar Documents

Publication Publication Date Title
PT74246B (en) Process for preparing hbsag
DK162586A (da) Substrat til jordloes plantedyrkning
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
PT86318A (en) Process for the preparation of immunogenic proteins
PT73371A (en) A method for enhancing the yield of hepatitis a virus
HUT39454A (en) Process for preparing derivatives of glycero-phosphocholine and glycero-phospho-ethanolamine
FI892312A0 (fi) Expression av hepatitis b, s och pres2 proteiner i metylotropiska jaester.
NO922953D0 (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
FR2657884B1 (fr) Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
DE2964185D1 (en) Process for preparing p,p'-biphenol of high purity
IL81857A0 (en) In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
AU2888089A (en) Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
NZ239948A (en) Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
ZA88990B (en) A process for the inactivation of viruses having envelopes in protein preparations prepared in vitro with the aid of a cell
PT87388A (pt) Process for preparing a stable lyophilized live herpes virus vaccine
DK42188A (da) Fremgangsmaade til dyrkning af aktiverede draeberceller
IE810688L (en) HBsAg FROM A HEPATOMA
GR3018918T3 (en) Artificial viral envelopes
DE3562900D1 (en) Process for preparing adducts of alcohols, ethers and esters with 1,2-dichlorodifluoroethylene
GR3015139T3 (en) 4-Amino-3-hydroxy-phthalide and a method for its preparation.
ZA868611B (en) Fermentation methods for hepatitis vaccine production
AR243231A1 (es) Procedimiento para producir medios de cultivo.